-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AcSEvvLAdGpgFuL2aOAXx8BI/rw9rNFVxziz78/mQDOKrOzd0P32lOseL25GOs8z PEpJMq5NWLav3693OzIPfQ== 0001193125-09-025218.txt : 20090211 0001193125-09-025218.hdr.sgml : 20090211 20090211134610 ACCESSION NUMBER: 0001193125-09-025218 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090211 DATE AS OF CHANGE: 20090211 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Li Ge CENTRAL INDEX KEY: 0001424321 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 86-21-5046 3309 MAIL ADDRESS: STREET 1: 288 FUTE ZHONGLU STREET 2: WAIGAOQIAO FREE TRADE ZONE CITY: SHANGHAI STATE: F4 ZIP: 200131 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WuXi PharmaTech (Cayman) Inc. CENTRAL INDEX KEY: 0001403132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-83350 FILM NUMBER: 09588863 BUSINESS ADDRESS: STREET 1: 288 FUTE ZHONG ROAD STREET 2: WAIGAOQIAO FREE TRADE ZONE CITY: SHANGHAI STATE: F4 ZIP: 200131 BUSINESS PHONE: 86-21-5046-1111 MAIL ADDRESS: STREET 1: 288 FUTE ZHONG ROAD STREET 2: WAIGAOQIAO FREE TRADE ZONE CITY: SHANGHAI STATE: F4 ZIP: 200131 SC 13G/A 1 dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 1 Schedule 13G Amendment No. 1

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Amendment No. 1)

 

Under the Securities Exchange Act of 1934

 

 

 

 

WuXi PharmaTech (Cayman) Inc.

(Name of Issuer)

 

 

Ordinary Shares*

American Depositary Shares

(Title of Class of Securities)

 

 

929352102**

(CUSIP Number)

 

 

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

 

* Not for trading, but only in connection with the registration of American Depositary Shares each representing 8 ordinary shares.

 

** This CUSIP applies to the American Depositary Shares.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 929352102    SCHEDULE 13G    Page 2 of 5 Pages

 

  1  

NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Ge Li

    
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

    
  3  

SEC USE ONLY

 

    
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            United States of America

    

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

  

  5    SOLE VOTING POWER

 

                35,610,4871

 

  6    SHARED VOTING POWER

 

                0

 

  7    SOLE DISPOSITIVE POWER

 

                35,610,4871

 

  8    SHARED DISPOSITIVE POWER

 

                0

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            35,610,4871

    
10  

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

  

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

            6.6%2

    
12  

TYPE OF REPORTING PERSON*

 

            IN

    

 

1

Includes (i) 5,660,596 ordinary shares held directly by Dr. Ge Li; (ii) 170,000 American Depository Shares, each representing 8 ordinary shares, held directly by Dr. Li; (iii) 15,509,891 ordinary shares held by J.P. Morgan Trust Company of Delaware, as Trustee of the Ning Zhao 2006 Grantor Retained Annuity Trust, for which Dr. Li is the Investment Advisor and exercises sole dispositive and voting power; (iii) 12,750,000 ordinary shares issuable upon the exercise of stock options held by Dr. Li, which includes stock options vesting within 60 days of December 31, 2008; and (iv) 330,000 shares of restricted stock, each representing 1 ordinary share, including shares of restricted stock vesting within 60 days of December 31, 2008.

2

Based on 542,465,590 total shares, which includes (i) 529,385,590 outstanding ordinary shares as of December 31, 2008; and (ii) 13,080,000 ordinary shares issuable pursuant to stock options or shares of restricted stock held by Dr. Li.

CUSIP No. 929352102    SCHEDULE 13G    Page 3 of 5 Pages

 

Item 1  

(a)

    Name of Issuer:      
     WuXi PharmaTech (Cayman) Inc. (“Issuer”)      
Item 1  

(b)

    Address of Issuer’s Principal Executive Offices:      
     288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s Republic of China      
Item 2  

(a)

    Name of Person Filing:      
     Ge Li      
Item 2  

(b)

    Address of Principal Business Office or, If None, Residence; Citizenship      
    

Ge Li

c/o WuXi PharmaTech (Cayman) Inc.

288 Fute Zhong Road

Waigaoqiao Free Trade Zone

Shanghai 200131

People’s Republic of China

      
Item 2  

(c)

    Citizenship      
     United States of America      
Item 2  

(d)

    Title of Class of Securities:      
    

Ordinary shares, par value US$0.02

American Depositary Shares

      
Item 2  

(e)

    CUSIP Number:      
     929352102      
Item 3.      Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c):      
     Not applicable.      

CUSIP No. 929352102    SCHEDULE 13G    Page 4 of 5 Pages

 

Item 4.    Ownership      
   (a)    Amount Beneficially Owned:      

 

Reporting Person

  

Amount

beneficially

owned:

  

Percent

of class:

  

Sole power

to vote or

direct

the vote:

  

Shared

power to

vote or to

direct

the vote:

  

Sole power to

dispose or to

direct the

disposition of:

  

Shared power

to dispose or to

direct the

disposition of:

Ge Li

  

35,610,487

ordinary

shares

   6.63%  

35,610,487

ordinary

shares

   0  

35,610,487

ordinary

shares

   0

 

Item 5.    Ownership of Five Percent or Less of a Class   
   Not applicable.   
Item 6.    Ownership of More Than Five Percent on Behalf of Another Person      
   Not applicable.      
Item 7.    Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
   Not applicable.
Item 8.    Identification and Classification of Members of the Group      
   Not applicable.      
Item 9.    Notice of Dissolution of Group      
   Not applicable.      
Item 10.    Certifications      
   Not applicable.      

 

3

Based on 542,465,590 total shares, which includes (i) 529,385,590 outstanding ordinary shares as of December 31, 2008; and (ii) 13,080,000 ordinary shares issuable pursuant to stock options or shares of restricted stock held by Dr. Li.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 9, 2009

 

Ge Li

/s/ Ge Li

 -----END PRIVACY-ENHANCED MESSAGE-----